MCL1 and hematologic disorder: As an antiapoptotic protein, MCL-1 has become an attractive target and is implicated with venetoclax resistance in hematologic malignancies [7], motivating us to investigate AZD5991 alone and in combination with venetoclax in our resistant MCL models.